Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Israel

19 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Growth slows due to shorter, warmer winters

Cough, cold and allergy remedies are very seasonal products and are therefore much affected by the changes in weather and climate. Therefore, as winters have been getting shorter and warmer, volume growth has slowed down significantly and is set to continue decreasing over the forecast period.

Paediatric cough/cold remedies dominated by nasal sprays

Several paediatric cough/cold remedies were taken off the shelves two years ago after the Ministry of Health banned the use of pseudoephedrine in combination with other components in paediatric remedies. These include products such as Acamoli Cold and Sinufed Kid, which have not been replaced by other, pseudoephedrine-free versions, but instead simply disappeared from the market.

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries reclaims leading OTC portfolio

Teva Pharmaceutical Industries Ltd leads the category thanks to its brands Acamol and Coldex, which are dominant in combination products, and Alrin, which is dominant in nasal sprays. These brands are widely recognised, and often consumers' go-to products for congestion and colds.

Dexcel Pharma and GSK support strong brands

Dexcel Pharma Ltd and GSK Consumer Healthcare both gained share during the past two years, thanks to their dominance in large or growing subcategories such as combination products, with Dexcel's Dexamol Cold, and GSK's Otrivin. With these strong brands, which are both supported by seasonal advertising campaigns, they are expected to continue gaining share over the forecast period too, although actual sales may decrease due to the general slowdown in the category.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Israel with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Israel, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Israel market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Israel?
What are the major brands in Israel?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category analysis

HEADLINES

PROSPECTS

Growth slows due to shorter, warmer winters

Paediatric cough/cold remedies dominated by nasal sprays

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries reclaims leading OTC portfolio

Dexcel Pharma and GSK support strong brands

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 Sales of Decongestants by Category: Value 2013-2018
Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues growing

Stricter regulation affects consumer health developments

Vitamins and dietary supplements player Solgar leads consumer health

Chained pharmacies more dominant, internet grows slowly

Future growth mainly in vitamins and dietary supplements

MARKET INDICATORS

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Israel

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Growth slows due to shorter, warmer winters

Paediatric cough/cold remedies dominated by nasal sprays

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries reclaims leading OTC portfolio

Dexcel Pharma and GSK support strong brands

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category analysis

HEADLINES

PROSPECTS

Growth slows due to shorter, warmer winters

Paediatric cough/cold remedies dominated by nasal sprays

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries reclaims leading OTC portfolio

Dexcel Pharma and GSK support strong brands

CATEGORY DATA

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues growing

Stricter regulation affects consumer health developments

Vitamins and dietary supplements player Solgar leads consumer health

Chained pharmacies more dominant, internet grows slowly

Future growth mainly in vitamins and dietary supplements

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports